NCT01472081 · Interventional trial
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)
Overall registry status Completed
Phase 1
Conditions Clear-cell Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory